Skip to main content

Table 1 mRNA and protein expression levels of HEPACAM1 and 2 in tissue samples of non-neoplastic canine mammary gland and canine mammary tumours

From: HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases

Gene

Normal gland

Adenoma

Carcinoma

IVTC

Lymph node metastases

Average fold change in mRNA expression levels relative to normal gland of the same dog

HEPACAM1*

1

5.2 (SD ± 2.4)

1.9 (SD ± 1.2)

-

1.5 (SD ± 1.2)

HEPACAM2*

1

4.0 (SD ± 2.0)

0.1 (SD ± 0.4)

-

0.1 (SD ± 0.3)

Percentage of immunohistochemical HEPACAM positive tissue samples

HEPACAM1

100%

13%

94%

95%

89%

  1. IVTC: Intravascular tumour cells
  2. * Significant differences (p < 0.05) in mRNA expression levels were observed between microdissected adenomas/carcinomas and adenomas/lymph node metastases (ANOVA)